SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001214659-15-002986
Filing Date
2015-04-09
Accepted
2015-04-09 17:12:06
Documents
3
Effectiveness Date
2015-04-09

Document Format Files

Seq Description Document Type Size
1 f48150defa14a.htm DEFA14A 43425
2 anlogo.jpg GRAPHIC 19746
3 truessig.jpg GRAPHIC 5909
  Complete submission text file 0001214659-15-002986.txt   80011
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34637 | Film No.: 15762044
SIC: 2834 Pharmaceutical Preparations